Autolus Therapeutics (AUTL) Profit After Tax: 2017-2025
Historic Profit After Tax for Autolus Therapeutics (AUTL) over the last 8 years, with Sep 2025 value amounting to -$79.1 million.
- Autolus Therapeutics' Profit After Tax rose 3.63% to -$79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.8 million, marking a year-over-year increase of 16.81%. This contributed to the annual value of -$220.7 million for FY2024, which is 5.90% down from last year.
- Latest data reveals that Autolus Therapeutics reported Profit After Tax of -$79.1 million as of Q3 2025, which was down 65.11% from -$47.9 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Profit After Tax registered a high of $116.2 million during Q2 2022, and its lowest value of -$242.5 million during Q4 2021.
- Over the past 3 years, Autolus Therapeutics' median Profit After Tax value was -$52.7 million (recorded in 2024), while the average stood at -$56.9 million.
- Data for Autolus Therapeutics' Profit After Tax shows a peak YoY increase of 250.22% (in 2022) and a maximum YoY decrease of 248.29% (in 2022) over the last 5 years.
- Over the past 5 years, Autolus Therapeutics' Profit After Tax (Quarterly) stood at -$242.5 million in 2021, then skyrocketed by 88.88% to -$27.0 million in 2022, then plummeted by 186.04% to -$77.2 million in 2023, then surged by 64.24% to -$27.6 million in 2024, then grew by 3.63% to -$79.1 million in 2025.
- Its last three reported values are -$79.1 million in Q3 2025, -$47.9 million for Q2 2025, and -$70.2 million during Q1 2025.